![Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual Meeting | Business Wire Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual Meeting | Business Wire](https://mms.businesswire.com/media/20220606005041/en/739014/23/teva_RGB_JPEG.jpg)
Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual Meeting | Business Wire
![Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | BioSpace Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | BioSpace](https://mms.businesswire.com/media/20210408005437/en/868792/4/Teva_Canada_-_AJOVY_Autoinjector.jpg)
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | BioSpace
![SeaFirst on Twitter: "#Ajovy approved by FDA. #teva sells #Celltrion will make it in Korea. https://t.co/tKTp91jDXs" / Twitter SeaFirst on Twitter: "#Ajovy approved by FDA. #teva sells #Celltrion will make it in Korea. https://t.co/tKTp91jDXs" / Twitter](https://pbs.twimg.com/media/DnHoyU0U0AANGSd.jpg)
SeaFirst on Twitter: "#Ajovy approved by FDA. #teva sells #Celltrion will make it in Korea. https://t.co/tKTp91jDXs" / Twitter
![These highlights do not include all the information needed to use AJOVY safely and effectively. See full prescribing information for AJOVY.AJOVY® (fremanezumab-vfrm) injection, for subcutaneous useInitial U.S. Approval: 2018 These highlights do not include all the information needed to use AJOVY safely and effectively. See full prescribing information for AJOVY.AJOVY® (fremanezumab-vfrm) injection, for subcutaneous useInitial U.S. Approval: 2018](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-30.jpg&id=705616)